相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Guidelines for the diagnosis and management of multiple myeloma 2011
Jennifer M. Bird et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners
Alex Molassiotis et al.
PSYCHO-ONCOLOGY (2011)
Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies
E. Nobile-Orazio et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
A 3-day short course of palifermin before HDT reduces toxicity and need for supportive care after autologous blood stem-cell transplantation in patients with multiple myeloma
G. Kobbe et al.
ANNALS OF ONCOLOGY (2010)
American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer
J. Douglas Rizzo et al.
BLOOD (2010)
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients
Sara Bringhen et al.
BLOOD (2010)
Innovative pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: a large observational study under conditions of daily practice
U. Schutter et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
S. Vincent Rajkumar et al.
LANCET ONCOLOGY (2010)
Cancer Pain: Part 2: Physical, Interventional and Complimentary Therapies; Management in the Community; Acute, Treatment-Related and Complex Cancer Pain: A Perspective from the British Pain Society Endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners
Jon Raphael et al.
PAIN MEDICINE (2010)
Cancer Pain: Part 1: Pathophysiology; Oncological, Pharmacological, and Psychological Treatments: A Perspective from the British Pain Society Endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners
Jon Raphael et al.
PAIN MEDICINE (2010)
Sublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: results from a randomized phase II study
Bo Lennernas et al.
PALLIATIVE MEDICINE (2010)
Management of oral and gastrointestinal mucositis: ESMO Clinical Recommendations
D. E. Peterson et al.
ANNALS OF ONCOLOGY (2009)
Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma
Heinz Ludwig et al.
BLOOD (2009)
UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)
Jenny Bird et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Fentanyl Buccal Tablet for the Treatment of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Cancer Pain A Long-term, Open-Label Safety Study
Sharon M. Weinstein et al.
CANCER (2009)
Topical 5% Lidocaine (Lignocaine) Medicated Plaster Treatment for Post-Herpetic Neuralgia Results of a Double-Blind, Placebo-Controlled, Multinational Efficacy and Safety Trial
Andreas Binder et al.
CLINICAL DRUG INVESTIGATION (2009)
5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study
Ralf Baron et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Pharmacology and treatment of neuropathic pains
Troels S. Jensen et al.
CURRENT OPINION IN NEUROLOGY (2009)
The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with Bone Metastases: The EORTC QLQ-BM22
Edward Chow et al.
EUROPEAN JOURNAL OF CANCER (2009)
The management of cancer-related breakthrough pain: Recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland
Andrew N. Davies et al.
EUROPEAN JOURNAL OF PAIN (2009)
Expected long-term survival of patients diagnosed with multiple myeloma in 2006-2010
Hermann Brenner et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Single-Agent Bortezomib in Previously Untreated Multiple Myeloma: Efficacy, Characterization of Peripheral Neuropathy, and Molecular Correlations With Response and Neuropathy
Paul G. Richardson et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Assessing Persistent Cancer Pain: A Comparison of Current Pain Ratings and Pain Recalled from the Past Week
Qiuling Shi et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2009)
A Pilot Study Evaluating the Safety and Efficacy of Modafinal for Cancer- Related Fatigue
Leslie Blackhall et al.
JOURNAL OF PALLIATIVE MEDICINE (2009)
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials
Julia Bohlius et al.
LANCET (2009)
Ascorbic acid inhibits antitumor activity of bortezomib in vivo
G. Perrone et al.
LEUKEMIA (2009)
Bisphosphonate-related osteonecrosis: genetic and acquired risk factors
M. E. Sarasquete et al.
ORAL DISEASES (2009)
Efficient assessment of neuropathic pain drugs in patients with small fiber sensory neuropathies
T. W. Ho et al.
PAIN (2009)
Responsiveness of the Harris Hip Score and the SF-36: five years after total hip arthroplasty
Hon-Yi Shi et al.
QUALITY OF LIFE RESEARCH (2009)
The use of cognitive interviewing methodology in the design and testing of a screening tool for supportive and palliative care needs
Nisar Ahmed et al.
SUPPORTIVE CARE IN CANCER (2009)
Surgical approaches to metastatic spine disease
Krzysztof Siemionow et al.
Current Opinion in Supportive and Palliative Care (2009)
Vertebroplasty in multiple myeloma: Outcomes in a large patient series
R. J. McDonald et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2008)
Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma
Sigurdur Y. Kristinsson et al.
BLOOD (2008)
Thalidomide for treatment of multiple myeloma: 10 years later
Antonio Palumbo et al.
BLOOD (2008)
Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature
Andreas A. Argyriou et al.
BLOOD (2008)
Should prophylactic granulocyte-colony stimulating factor be used in multiple myeloma patients developing neutropenia under lenalidomide-based therapy?
Maria-Victoria Mateos et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Thromboembolic events with lenalidomide-based therapy for multiple myeloma
Smitha Patiyil Menon et al.
CANCER (2008)
Curcumin: From ancient medicine to current clinical trials
H. Hatcher et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Antithrombotic therapy for venous thromboembolic disease
Clive Kearon et al.
CHEST (2008)
Herbal Compounds and Toxins Modulating TRP Channels
Rudi Vennekens et al.
Current Neuropharmacology (2008)
Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies
Sherry Wolf et al.
EUROPEAN JOURNAL OF CANCER (2008)
Review of peripheral neuropathy in plasma cell disorders
Jeannine Silberman et al.
HEMATOLOGICAL ONCOLOGY (2008)
Natural History of Osteonecrosis of the Jaw in Patients With Multiple Myeloma
Ashraf Badros et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue
Ollie Minton et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Methylnaltrexone for opioid-induced constipation in advanced illness
Jay Thomas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Bisphosphonate-induced osteonecrosis of the jaws: Prospective study of 80 patients with multiple myeloma and other malignancies
Thacharot Boonyapakorn et al.
ORAL ONCOLOGY (2008)
Gabapentin Monotherapy for the Treatment of Chemotherapy-Induced Neuropathic Pain: A Pilot Study
Nicolas Tsavaris et al.
PAIN MEDICINE (2008)
Features and risk factors of peripheral neuropathy during treatment with bortezomib for advanced multiple myeloma
Jean El-Cheikh et al.
CLINICAL LYMPHOMA & MYELOMA (2008)
Recent major improvement in long-term survival of younger patients with multiple myeloma
Hermann Brenner et al.
BLOOD (2008)
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
A. Palumbo et al.
LEUKEMIA (2008)
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Meletios Dimopoulos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America
Donna M. Weber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Multiple myeloma: causes and consequences of delay in diagnosis
C. C. Kariyawasan et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2007)
Meta-analysis: Effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection
Lillian Sung et al.
ANNALS OF INTERNAL MEDICINE (2007)
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale
Guido Cavaletti et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2007)
Gabapentin and an opioid combination versus opioid alone for the management of neuropathic cancer pain: A randomized open trial
Kader Keskinbora et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2007)
An internadional field study of the reliability and validity of a disease-specfic questionnanire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma
K. Cocks et al.
EUROPEAN JOURNAL OF CANCER (2007)
Critical review: Updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients - May 2006
Richard Weitzman et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia
Tony Mavrokokki et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2007)
Using screening tools to identify neuropathic pain
Michael I. Bennett et al.
PAIN (2007)
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer:: 2006 update
C. Bokemeyer et al.
EUROPEAN JOURNAL OF CANCER (2007)
Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature
Ashraf Badros et al.
CANCER (2007)
Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer
Charles L. Bennett et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
The effectiveness of commonly used mouthwashes for the prevention of chemotherapy-induced oral mucositis: a systematic review
C. M. J. Potting et al.
EUROPEAN JOURNAL OF CANCER CARE (2006)
A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma
Paul G. Richardson et al.
BLOOD (2006)
Evaluation of anaemia in patients with multiple myeloma and lymphoma:: findings of the European CANCER ANAEMIA SURVEY
Gunnar Birgegard et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2006)
Specific killing of multiple myeloma cells by (-)-epigaflocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications
Masood A. Shammas et al.
BLOOD (2006)
Development of neuropathy in patients with myeloma treated with thalidomide: Patterns of occurrence and the role of electrophysiologic monitoring
Linda Mileshkin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Opioids in pain management of blood-related malignancies
Pasquale Niscola et al.
ANNALS OF HEMATOLOGY (2006)
Thrombotic complications in patients with newly diagnosed multiple myeloma treated with lenalidomide and dexamethasone: benefit of aspirin prophylaxis
JA Zonder et al.
BLOOD (2006)
Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib
Paul G. Richardson et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Validation of the distress thermometer with bone marrow transplant patients
Sean Ransom et al.
PSYCHO-ONCOLOGY (2006)
American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006
Mark G. Kris et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Oxycodone for cancer-related pain - Meta-analysis of randomized controlled trials
CM Reid et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled-trial
A Palumbo et al.
LANCET (2006)
Current evidence for a genetic modulation of the response to analgesics
J Lötsch et al.
PAIN (2006)
Acquired von Willebrand syndrome: an underdiagnosed and misdiagnosed bleeding complication in patients with lymphoproliferative and myeloproliferative disorders
AB Federici
SEMINARS IN HEMATOLOGY (2006)
Early mortality after diagnosis of multiple myeloma: Analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002 - Medical Research Council Adult Leukaemia Working Party
BM Augustson et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycline-based chemotherapy for multiple myeloma
R Baz et al.
MAYO CLINIC PROCEEDINGS (2005)
Complementary and alternative medicine use in colorectal cancer patients in seven European countries
A Molassiotis et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2005)
Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment
A Shafqat et al.
ANNALS OF ONCOLOGY (2005)
Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species
T Nakazato et al.
CLINICAL CANCER RESEARCH (2005)
Thalidomide-dexamethasone as primary therapy for advanced multiple myeloma
M Wang et al.
AMERICAN JOURNAL OF HEMATOLOGY (2005)
Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma
S Jagannath et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM)
TJ Smith et al.
ANNALS OF ONCOLOGY (2005)
Bortezornib in recurrent and/or refractory multiple myeloma - Initial clinical experience in patients with impaired renal function
S Jagannath et al.
CANCER (2005)
Recommendations for influenza and pneumococcal vaccinations in people receiving chemotherapy
L Melcher
CLINICAL ONCOLOGY (2005)
Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis
L Shaiova et al.
SUPPORTIVE CARE IN CANCER (2004)
Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation
M Zangari et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain
AJ Clark et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Monoclonal gammopathy of undetermined significance and multiple myeloma are associated with an increased incidence of venothromboembolic disease
G Srkalovic et al.
CANCER (2004)
Gabapentin for neuropathic cancer pain: A randomized controlled trial from the gabapentin cancer pain study group
A Caraceni et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Thalidomide sensory neurotoxicity - A clinical and neurophysiologic study
G Cavaletti et al.
NEUROLOGY (2004)
Guidelines on the diagnosis and management of AL amyloidosis
J Bird et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Pyridoxine (Vitamin B6) neurotoxicity: Enhancement by protein-deficient diet
S Levine et al.
JOURNAL OF APPLIED TOXICOLOGY (2004)
The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from rive randomized clinical trials
D Cella et al.
ANNALS OF ONCOLOGY (2004)
Opioid therapy for chronic pain
JC Ballantyne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Feasibility of exercise during treatment for multiple myeloma
EA Coleman et al.
CANCER NURSING (2003)
Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies:: a randomized, double-blind, placebo-controlled study
M Hedenus et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
AYY Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment
A Trotti et al.
SEMINARS IN RADIATION ONCOLOGY (2003)
A phase 2 study of bortezomib in relapsed, refractory myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation
AS Papas et al.
BONE MARROW TRANSPLANTATION (2003)
Oral opioid therapy for chronic peripheral and central neuropathic pain
MC Rowbotham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Recent developments -: Management of pain
A Holdcroft et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases
JSY Wu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis
AC Bharti et al.
BLOOD (2003)
Review of 1027 patients with newly diagnosed multiple myeloma
RA Kyle et al.
MAYO CLINIC PROCEEDINGS (2003)
Perentaneons vertebroplasty in the treatment of malignant spine disease
ME Jensen et al.
CANCER JOURNAL (2002)
Report of three cases of circulating heparin-like anticoagulants
P Liamas et al.
AMERICAN JOURNAL OF HEMATOLOGY (2001)
The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs
M Bennett
PAIN (2001)
Recombinant human factor VIIa in the management of amyloid-associated factor X deficiency
L Boggio et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis
AD Mumford et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma
JD Robertson et al.
BRITISH JOURNAL OF CANCER (2000)
分享论文
